Skip to main content
Equibles

PHG · Koninklijke Philips NV · Documents

Track PHG — free

Use PHG with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research PHG.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$30.51 -0.55 (-1.77%) At close · Nov 5 Play latest call Q2 2026 earnings call transcript
Rebalance outlook locked
Market Cap
$30.15B
Shares
977.61M
Volume · Nov 5 3.19M Avg daily vol (3M) 1.07M

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

Annual report FY2025 Revenue 17.83B EUR down 1.0% 20-F filed Feb 19, 2026 Earnings call Q2 2026 earnings call Held Jul 28, 2026
2026
Nov 3
Current report 6-K
Current report

KONINKLIJKE PHILIPS N.V. reported Q3 2026 sales of EUR 4.4 billion, 3% comparable sales growth, 8% comparable order intake growth and a 13.0% adjusted EBITA margin. A EUR 288 million Respironics DOJ settlement provision was recorded; 2026 outlook was reiterated.

Feb 19
Annual report 20-F FY2025, ended Dec 31
Annual report for FY2025 AI summary on its way
Revenue 17.83B EUR ▼ 1.0% Net income 895M EUR Diluted EPS 0.93 EUR
2025
Feb 21
Annual report 20-F FY2024, ended Dec 31
Annual report for FY2024
Revenue 18.02B EUR ▼ 0.8% Net loss 702M EUR Diluted EPS -0.75 EUR
2024
Feb 20
Annual report 20-F FY2023, ended Dec 31
Annual report for FY2023
Revenue 18.17B EUR ▲ 1.9% Net loss 466M EUR Diluted EPS -0.51 EUR
Showing 1–50 of 159 documents
Key facts CIK 313216 CUSIP 500472303 13F (30d) 183 filings 152 filers Visit website Investor relations